Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Delisting risk
confidence 92%
filed 2026-07-07
Item 7.01
BIO-key's disclosure announces the reinstatement of trading on Nasdaq Capital Market following a June 16th hearing where the Nasdaq Hearings Panel determined the Company "has regained compliance with the continued listing standards, including minimum bid price and SEC filing requirements." This directly addresses a delisting risk event—the company had previously been subject to a trading halt due to non-compliance with listing standards and has now resolved that issue. The materiality is clear: trading suspension and reinstatement materially affect investor access to the stock and the company's market standing.
View raw filing on EDGAR →
8-K
Exec departure
confidence 85%
filed 2026-07-07
Item 5.02
Lori M. Toomey, a Board member and Executive Committee member, has determined not to stand for re-election at the 2027 annual meeting, constituting a planned departure from her director role.
View raw filing on EDGAR →
8-K
Covenant Breach
confidence 72%
filed 2026-07-07
Item 7.01
The Toomey Directors' decision not to extend or renew the Toomey Loan (maturing December 31, 2026, with $365,000 principal and $9,191 accrued interest) creates a material liquidity crisis, with risk of cascading defaults on senior secured debt if the Company cannot refinance the obligation.
View raw filing on EDGAR →
8-K
Operational Other
confidence 85%
filed 2026-07-07
Aptera announced receipt of an EPA Certificate of Conformity for its 2026 Launch Edition vehicle on June 18, 2026. The filing describes this as "an important federal emissions compliance milestone" and "one of the two primary federal certifications required before a vehicle can be legally sold in the United States." This is a material operational and regulatory milestone for a pre-revenue automotive manufacturer advancing toward commercialization, though it does not fit the specific categories of earnings, M&A, impairment, litigation, or other named event types.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 98%
filed 2026-07-07
EX-99.1
The exhibit is a press release announcing the appointment of Arie Goor as Chief Financial Officer of Core AI Holdings, effective July 1, 2026. The disclosure explicitly states "Core AI Holdings Appoints Arie Goor as Chief Financial Officer" and provides detailed background on his qualifications and prior experience. This is a clear executive appointment of a named officer to a material C-suite position, which would affect a reasonable investor's assessment of the company's leadership and financial management capabilities.
View raw filing on EDGAR →
8-K
Earnings release
confidence 92%
filed 2026-07-07
Item 8.01
The filing discloses quarterly financial results for Q2 2026 in a press release format (Exhibit 99.1), reporting "greater than 100% growth in revenue and new customers" compared to Q1 2026. This is a material earnings disclosure showing significant commercial traction following the LIBERTY System's Full Market Release in April 2026, including expansion of sales territories and entry into federal healthcare systems.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-07
The filing discloses the completion of a material disposition: on June 30, 2026, Glimpse Group sold all membership interests in Glimpse Learning, LLC (a wholly-owned subsidiary) to Glimpse Learning, Inc. pursuant to a Master Purchase Agreement. The transaction involves transfer of a business unit with associated intellectual property, technology, and contracts, with consideration including equity in the buyer (19.99% interest), ongoing royalty payments, and assumption of liabilities. Item 1.01 and Item 2.01 explicitly document entry into and completion of this material asset disposition.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-07-07
The filing discloses a press release announcing significant commercial sales acceleration for CyPath® Lung with over 200% year-over-year growth and 30% sequential growth, along with expansion metrics (155% increase in physician offices ordering). While this is a business milestone announcement, it does not fit the specific earnings_release category (which typically reports comprehensive quarterly financial results) but rather represents an operational/commercial milestone. The material growth metrics and market expansion data would affect a reasonable investor's assessment of the company's commercial trajectory and product adoption.
View raw filing on EDGAR →
8-K
Auditor Change
confidence 92%
filed 2026-07-07
The filing discloses under Item 4.01 that the Company's principal auditor BCRG had its attest business acquired by Simon & Edward LLP (S&E), and the Company will continue receiving audit services from the combined firm. Although technically a business acquisition rather than a resignation or dismissal, this constitutes a material change in the registrant's independent accountant, as the audit function transitions from BCRG to S&E. The disclosure includes the required representations that BCRG's prior audit reports contained no disclaimers, adverse opinions, or disagreements.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 75%
filed 2026-07-07
Item 2.03
The filing discloses creation of new direct financial obligations through three convertible promissory notes dated June 30, 2026, issued to CPC Sponsor Opportunities I, LP, CPC Sponsor Opportunities I (Parallel), LP, and NovoCG, LLC, along with an omnibus note exchange and debt conversion agreement. While Item 9.01 lists exhibits rather than Item 2.03 directly, the substance reflects debt issuance activity involving convertible debt instruments and debt restructuring.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 92%
filed 2026-07-07
Item 2.03
The Company entered into an amended and restated SEPA with Yorkville on June 26, 2026, and issued a $2.0 million Promissory Note (with 5% original issue discount, yielding ~$1.8 million in gross proceeds) on June 30, 2026. The Promissory Note is a direct financial obligation bearing 5% interest (escalating to 18% upon default), maturing June 30, 2027, and convertible into Class A common stock. This constitutes creation of a new direct financial obligation under Item 2.03, with an additional $2.0 million Promissory Note to follow upon SEC registration statement effectiveness. The dilutive conversion feature and material terms make this a significant capital-raising event.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-07-07
The 6-K discloses a private placement of 331,753,557 ordinary shares and 995,260,671 warrants for US$700 million, closed on July 3, 2026. This is a material unregistered equity issuance that dilutes existing shareholders and raises substantial capital. The transaction is explicitly described as a private placement under a Securities Purchase Agreement, fitting the definition of dilutive_issuance.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-07-07
Item 3.03
Tecnoglass completed a change of incorporation jurisdiction from the Cayman Islands to Florida effective July 7, 2026, resulting in a material modification of shareholder rights. Ordinary shares became registered common stock under Florida law, with substantive differences in governance rights between Cayman and Florida law.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-07
XMax Inc. entered into Securities Purchase Agreements on July 1, 2026, to sell 434,600 shares of common stock at $8.454 per share for an aggregate offering price of $3,674,108.40 in a private placement to non-U.S. investors under Regulation S. This is a classic unregistered equity issuance disclosed under Item 1.01 and Item 3.02, representing dilutive capital raising activity material to investors assessing ownership and equity structure.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 85%
filed 2026-07-07
NextNRG entered into a Merchant Cash Advance (MCA) agreement with Avanza Capital on June 30, 2026, creating a direct financial obligation. The Company received $940,000 in net proceeds in exchange for selling $1,499,900 of future receivables and committing to remit 25% of daily settlements until the purchased amount is delivered. While structured as a receivables purchase rather than traditional debt, the MCA functions as a secured financing obligation with fixed periodic payments ($62,496 estimated), security interests in substantially all assets, and default provisions—characteristics of debt issuance. The CEO personally guaranteed performance, underscoring materiality to investors assessing the Company's capital structure and financial obligations.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-07-07
The filing discloses Item 5.07 results from Mama's Creations' Annual Meeting of Stockholders held on July 2, 2026. The company reports voting outcomes for three proposals: election of five board directors (with specific vote tallies for each nominee), ratification of UHY LLP as independent auditor, and advisory approval of executive compensation. These are standard shareholder vote results that materially inform investors about governance and board composition.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-07
Item 2.01
The filing discloses the completion of a merger on June 30, 2026, in which Aeternum Health LLC merged with and into Shorepower Technologies, Inc., with Shorepower as the surviving entity. The merger resulted in a change of control, with Paul Mann receiving 49 million shares (51% ownership) and 2 million Series B preferred shares with enhanced voting power. The company also changed its name to Aeternum Health, Inc. and shifted its business focus from transportation electrification to critical minerals mining and longevity products. This is a material acquisition/change of control event under Item 2.01.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-07-07
The filing discloses entry into an Amended and Restated Senior Secured Convertible Note and Amended and Restated Loan Agreement on June 30, 2026, creating a direct financial obligation of $1,971,000 principal amount with $1,460,000 in proceeds. Item 1.01 and Item 2.03 both address this debt creation, which is a material financial obligation requiring 8-K disclosure under Item 2.03.
View raw filing on EDGAR →
8-K
Exec departure
confidence 75%
filed 2026-07-07
The filing discloses the resignation of Renger van den Heuvel, who held multiple critical roles: Chief Executive Officer, principal financial officer, principal accounting officer, and Board member. While the filing also mentions the appointment of Ana Rita Coelho as Interim CEO and the appointment of three new directors, the primary event is the departure of the CEO and principal financial/accounting officer. The appointment of an interim replacement and new board members are secondary governance actions responding to the departure.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-07-07
Polar Power issued a convertible promissory note to Mayers Ventures LLC for $250,000 consideration with conversion rights into common stock at a price equal to 90% of the lowest daily VWAP in the 7 trading days prior to conversion. The filing explicitly discloses this under Item 3.02 (Unregistered Sales of Equity Securities), and the convertible structure with a below-market conversion floor and registration rights agreement creates material dilution risk to existing shareholders. The investor also gains board designation rights, indicating a significant capital raise with equity upside.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-07-07
The 8-K discloses Item 2.02 (Results of Operations and Financial Condition) with a press release announcing preliminary operating results for Q2 2026 ended June 30, 2026. The filing reports key operational metrics including Consumer Loan Marketplace Volume of $4,259 million for Q2 2026 (47% Q/Q growth, 132% Y/Y growth), exceeding previously issued guidance ranges. This is a standard earnings/operating results disclosure furnished as Exhibit 99.1.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-07
The filing discloses a private placement (PIPE) of 3,608,496 units at $0.582 per unit, raising approximately $2.1 million in gross proceeds. Each unit comprises Series A Convertible Preferred Stock (convertible 1:1 to common stock), warrants to purchase common stock equal to 100% of conversion shares, and subscription rights. The transaction is explicitly exempt from registration under Section 4(a)(2) and Regulation D Rule 506(b), and Item 3.02 confirms unregistered sales of equity securities. This is a classic dilutive private placement raising capital through convertible securities and warrants.
View raw filing on EDGAR →
8-K
Material Litigation
confidence 85%
filed 2026-07-07
The filing discloses that on June 25, 2026, the U.S. District Court for the Southern District of Texas entered a temporary restraining order against the Company following a complaint filed by certain plaintiffs. This is a material litigation event. The filing also references a Nasdaq trading halt imposed on June 8, 2026, which compounds the materiality of the disclosure, though the trading halt itself appears to be a consequence of or related to the underlying legal matter.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-07-07
Item 5.02
The filing discloses both the retirement of Michael D. Hill as CFO (effective July 27, 2026) and the appointment of David Tamez as interim CFO (effective the same date). While both events occur, the principal action the Board has taken is the appointment of Tamez to fill the CFO role, making exec_appointment the most salient classification. The retirement is contextual background explaining why the appointment was necessary.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-07-07
Item 3.02
Wheeler Real Estate issued approximately 2.12 million shares of common stock across three tranches in June-July 2026 in exchange for preferred stock held by existing security holders, relying on Section 3(a)(9) exemption. Additionally, the Company issued approximately 739,883 shares cumulatively (275,883 in July 2026 and ~464,000 to date) through redemptions of Series D Cumulative Convertible Preferred Stock, with the conversion price of the 7.00% Subordinated Convertible Notes due 2031 adjusted downward to $0.67 per share, representing a 45% discount and material dilution to existing shareholders.
View raw filing on EDGAR →
8-K
Earnings release
confidence 92%
filed 2026-07-07
Item 8.01
The filing discloses HomeTrust Bancshares' intention to issue its second quarter 2026 earnings release on July 23, 2026. Although filed under Item 8.01 (Other Events) rather than the typical Item 2.02, the substance is an advance notice of an upcoming earnings release, which is material to investors assessing the company's financial performance and results.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-07-07
Item 1.01
Oportun entered into a Program Management Agreement with Column National Association on June 30, 2026, establishing a new lending program under which Column originates unsecured personal loans and Oportun provides platform services and can purchase loans. This is a material strategic partnership and operational arrangement that establishes a new revenue and lending channel, but it does not constitute a traditional M&A transaction, debt issuance, or other specifically-named event type. The agreement's four-year initial term with auto-renewal and exclusivity provisions indicate strategic significance to the business.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 92%
filed 2026-07-07
Item 8.01
Morgan Stanley Capital I Inc. (the Registrant) issued and sold commercial mortgage pass-through certificates on July 7, 2026, totaling $645.5 million in publicly offered certificates plus $66.8 million in privately offered certificates, funded by proceeds from the sale of these securities. This constitutes creation of a new direct financial obligation through issuance of debt-like securities backed by a pool of 70 commercial and multifamily mortgage loans, fitting the debt_issuance category. The transaction is material as it represents a substantial capital raise and creation of significant financial obligations.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-07-07
EX-99.1
This news release announces a major 2026 exploration and resource definition program at the Springer Tungsten Project, including a 67,000-metre diamond drilling program, re-logging of 18,000 metres of historical core, stockpile evaluation, tailings sampling, geophysical surveys, and metallurgical testing. The program is explicitly designed to advance the project toward a previously announced Q4-2027 production target. This is a material operational and strategic milestone for the company's development of a brownfield tungsten asset, affecting investor assessment of project advancement and near-term production feasibility.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 85%
filed 2026-07-07
Item 8.01
News Corporation discloses daily share repurchase activity under its authorized $1 billion repurchase program, with specific transaction details including 8,977,418 Class A shares and 66,163 Class B shares purchased on 07/07/2026 for approximately $227.5 million in aggregate consideration. Share repurchases constitute a form of capital return to shareholders and are material to investors assessing capital allocation and shareholder value enhancement.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-07
Item 5.02
Keith R. Wyche was appointed as a member of the Board of Directors of Internet Sciences, Inc., effective July 1, 2026. This is a clear executive appointment disclosed under Item 5.02. The appointment of a new director with substantial experience (including prior board service at NYSE-listed companies) is material to investors' assessment of the company's governance and leadership.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-07-07
Item 2.02
DigitalOcean issued a press release on July 7, 2026 announcing preliminary, unaudited financial results for Q2 2026, including revenue growth expectations of 29%, record RPO exceeding $800M (up 10X year-over-year), and guidance for aEBITDA margin and non-GAAP EPS at or above the high end of prior guidance. This is a classic earnings release disclosure under Item 2.02, material to investors assessing the company's financial performance and growth trajectory.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-07-07
Item 5.02
Courtney Mather resigned from the Board of Directors effective July 6, 2026. The disclosure centers on a director's departure, not an appointment or compensation arrangement. Board departures are material to investors as they affect governance and oversight structure. The filing explicitly states the resignation is not due to disagreement, but the departure itself remains a material governance event.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-07
Item 2.02
Penguin Solutions issued a press release on July 7, 2026 announcing Q3 fiscal 2026 financial results, including record net sales of $479 million (up 48% YoY), record GAAP operating income of $51 million (up 417% YoY), and Q3 GAAP diluted EPS of $0.68 versus $(0.01) in the prior year. The company also raised its full-year fiscal 2026 outlook for both net sales and EPS. This is a classic earnings release disclosure under Item 2.02, with the press release attached as Exhibit 99.1.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-07-07
Item 5.02
Kathy Elsesser was appointed to Lazard's Board of Directors effective July 7, 2026, and appointed to the Compensation Committee, succeeding Andrew M. Alper as Compensation Committee Chair. Alper retired from the Board after 13 years of service.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-07
Item 7.01
CuriosityStream announced completion of its acquisition of remaining ownership interests in its German operations from SPIEGEL TV and Autentic. The press release explicitly states this transaction "gives CuriosityStream sole ownership of one of its most important international markets" and describes Germany as "the company's largest and most important non-English-speaking market." This is a material acquisition that consolidates control of a key international business segment.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-07
Item 5.02
The filing discloses the election of Cynthia Paul as a Class I director to the Board of Yext, Inc., effective July 7, 2026. While the disclosure includes compensation details (initial RSU grant of $350,000 and annual equity eligibility), the principal action is the appointment of a new director with substantial experience in investment management and prior board service at multiple public companies. This is a clear exec_appointment event.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-07
Item 3.02
The filing discloses multiple unregistered sales of equity securities (Class E, I, and Y shares) to accredited investors across May, June, and July 2026, both through a distribution reinvestment plan and private placements, totaling approximately $36.7 million in aggregate purchase prices. These transactions are explicitly exempt under Section 4(a)(2) and Regulation D, and the Item 3.02 classification confirms this is a dilutive equity issuance material to investors assessing the company's capital structure and shareholder dilution.
View raw filing on EDGAR →
8-K
Exec departure
confidence 75%
filed 2026-07-07
Item 5.02
Steven Dassing resigned as Vice President, Corporate Controller and Principal Accounting Officer effective July 22, 2026. While the filing also discloses that Mr. Coler will assume the Principal Accounting Officer role, the principal disclosed action centers on Dassing's departure from a named executive officer position. The resignation of the Principal Accounting Officer is material to investors as it affects the registrant's financial reporting oversight and internal controls.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 85%
filed 2026-07-07
Item 2.03
Global Industrial amended its Third Amended and Restated Credit Agreement on June 30, 2026, extending the maturity date from October 19, 2026 to June 30, 2031, materially extending the term of its material credit facility and affecting its capital structure and liquidity profile.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 93%
filed 2026-07-07
Item 1.01
Postal Realty Trust entered into a Second Amended and Restated Credit Agreement on July 2, 2026, expanding its aggregate credit facilities from $555 million to $615 million ($275 million revolving facility and $340 million in term loans) with improved pricing of 30 basis points and extended maturity dates through 2030–2031. The facility includes a $335 million accordion feature and $35 million of new term loans advanced on the closing date.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-07-07
EX-99.1
This press release announces Phase 4 drill results from the Maestro Project, including significant gold-silver mineralization intercepts (164 metres of 0.72 g/t AuEQ) and expansion of the Prodigy discovery. The disclosure also reports re-assay results from historical drill core identifying additional high-grade gold values across the property. These are material operational/exploration milestones for a mineral exploration company that expand the resource potential and guide future drilling strategy, but do not constitute a discrete financial event (earnings release), M&A activity, or other named event type.
View raw filing on EDGAR →
8-K
Financial Other
confidence 72%
filed 2026-07-07
Item 1.01
Frontier entered into a binding agreement with Avolon to sell 11 A321neo aircraft at delivery, part of a fleet-rightsizing initiative. While this involves a material definitive agreement (Item 1.01), the transaction is fundamentally a sale of assets (aircraft) rather than a traditional M&A activity, debt issuance, or other specifically-named event type. The sale is material to investors as it affects fleet composition and capital deployment, but does not fit cleanly into `ma_activity` (which typically involves acquisitions, mergers, or changes of control) or other specific categories, warranting classification as `financial_other`.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 92%
filed 2026-07-07
Item 1.01
Lifeway entered into a Master Security Agreement with CIBC Bank USA providing for up to $22 million in loan advances under an Interim Funding Agreement to finance equipment acquisition, with conversion to a five-year Equipment Guidance Line Note at 1-month SOFR plus 1.65%.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-07-07
Item 1.01
Aethlon Medical entered into a Securities Purchase Agreement on July 6, 2026, to sell 263,000 shares of common stock, 5,633,009 common warrants, 5,370,009 pre-funded warrants, and 225,320 placement agent warrants in a registered public offering priced at $0.71 per unit, raising approximately $4.0 million in gross proceeds. This dilutive equity issuance materially increases the share count and warrant overhang, affecting existing shareholders' ownership percentages and future earnings per share.
View raw filing on EDGAR →
8-K
Operational Other
confidence 85%
filed 2026-07-07
Item 8.01
Praxis announced a research collaboration and license agreement with Remagine Labs to develop an iontophoretic transdermal patch for ulixacaltamide delivery, complemented by an equity investment in Remagine. This is a material strategic partnership and product development initiative that expands the company's pipeline and competitive positioning, but does not fit the specific operational categories (workforce reduction, restructuring) or other named event types. The collaboration and equity investment represent a significant operational and strategic commitment to advance the ulixacaltamide franchise.
View raw filing on EDGAR →
6-K
Delisting risk
confidence 95%
filed 2026-07-07
EX-99.1
The exhibit announces that CDT has regained compliance with Nasdaq's minimum bid price requirement (Nasdaq Listing Rule 5550(a)(2)) after receiving a notice on June 30, 2026 that the closing bid price met or exceeded $1.00 per share for 10 consecutive business days. This disclosure directly addresses a delisting risk — the prior non-compliance with the minimum bid price rule — and announces its resolution. The materiality is high because listing status is fundamental to a public company's continued trading and investor access.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-07-07
Item 1.01
Vivani entered into a definitive Merger Agreement on July 1, 2026, whereby its wholly owned subsidiary Cortigent will merge with ClearOne's merger subsidiary, resulting in Cortigent becoming a wholly owned subsidiary of ClearOne. Vivani shareholders will receive 12,500,000 shares of ClearOne common stock as consideration, subject to financing conditions requiring a $10–15 million capital raise for closing.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-07-07
Item 8.01
Vivani announced entry into an agreement with Novo Nordisk to evaluate NPM-139, a semaglutide implant candidate, leveraging Vivani's NanoPortal platform technology. This material strategic partnership with a major pharmaceutical company represents significant validation of the company's technology platform and development program.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-07-07
Item 5.02
Shawn Morris resigned from his position as a member of the Board of Directors and the Compliance Committee, effective immediately on July 6, 2026. This is a clear departure of a director from the registrant. Board composition changes are material to investors as they affect governance and oversight. The filing explicitly states the resignation was not due to disagreement, but the departure itself is the principal disclosed action.
View raw filing on EDGAR →